BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 11698484)

  • 1. Possible role of organ-specific autoantigen for Fas ligand-mediated activation-induced cell death in murine Sjögren's syndrome.
    Ishimaru N; Yanagi K; Ogawa K; Suda T; Saito I; Hayashi Y
    J Immunol; 2001 Nov; 167(10):6031-7. PubMed ID: 11698484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
    Kobayashi M; Yasui N; Ishimaru N; Arakaki R; Hayashi Y
    Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantigen-specific CD4+CD28low T cell subset prevents autoimmune exocrinopathy in murine Sjögren's syndrome.
    Saegusa K; Ishimaru N; Yanagi K; Haneji N; Nishino M; Azuma M; Saito I; Hayashi Y
    J Immunol; 2000 Aug; 165(4):2251-7. PubMed ID: 10925313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with anti-CD86 costimulatory molecule prevents the autoimmune lesions in murine Sjögren's syndrome (SS) through up-regulated Th2 response.
    Saegusa K; Ishimaru N; Yanagi K; Haneji N; Nishino M; Azuma M; Saito I; Hayashi Y
    Clin Exp Immunol; 2000 Feb; 119(2):354-60. PubMed ID: 10632675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and induction of autoimmune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjögren's syndrome.
    Saegusa K; Ishimaru N; Yanagi K; Mishima K; Arakaki R; Suda T; Saito I; Hayashi Y
    J Immunol; 2002 Jul; 169(2):1050-7. PubMed ID: 12097413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of in vivo role of alpha-fodrin autoantigen in primary Sjogren's syndrome.
    Miyazaki K; Takeda N; Ishimaru N; Omotehara F; Arakaki R; Hayashi Y
    Am J Pathol; 2005 Oct; 167(4):1051-9. PubMed ID: 16192640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of caspase cascade on the development of primary Sjögren's syndrome.
    Hayashi Y; Arakaki R; Ishimaru N
    J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of salivary gland epithelial cell injury in Sjogren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression.
    Abu-Helu RF; Dimitriou ID; Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
    J Autoimmun; 2001 Sep; 17(2):141-53. PubMed ID: 11591123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis.
    Ishimaru N; Yoneda T; Saegusa K; Yanagi K; Haneji N; Moriyama K; Saito I; Hayashi Y
    Am J Pathol; 2000 May; 156(5):1557-64. PubMed ID: 10793067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of neonatal tolerance induced in an animal model for primary Sjögren's syndrome by intravenous administration of autoantigen.
    Saegusa K; Ishimaru N; Haneji N; Yanagi K; Yoneda T; Saito I; Hayashi Y
    Scand J Immunol; 2000 Sep; 52(3):264-70. PubMed ID: 10972902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome.
    Yanagi K; Ishimaru N; Haneji N; Saegusa K; Saito I; Hayashi Y
    Eur J Immunol; 1998 Oct; 28(10):3336-45. PubMed ID: 9808203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome.
    Haneji N; Nakamura T; Takio K; Yanagi K; Higashiyama H; Saito I; Noji S; Sugino H; Hayashi Y
    Science; 1997 Apr; 276(5312):604-7. PubMed ID: 9110981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of autoimmune exocrinopathy resembling Sjögren's syndrome in adoptively transferred mice with autoreactive CD4+ T cells.
    Arakaki R; Ishimaru N; Saito I; Kobayashi M; Yasui N; Sumida T; Hayashi Y
    Arthritis Rheum; 2003 Dec; 48(12):3603-9. PubMed ID: 14674013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis in labial salivary glands from Sjögren's syndrome (SS) patients: comparison with human T lymphotropic virus-I (HTLV-I)-seronegative and -seropositive SS patients.
    Nakamura H; Koji T; Tominaga M; Kawakami A; Migita K; Kawabe Y; Nakamura T; Shirabe S; Eguchi K
    Clin Exp Immunol; 1998 Oct; 114(1):106-12. PubMed ID: 9764611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity.
    He J; Zhao J; Li Z
    Arthritis Res Ther; 2008; 10(2):R44. PubMed ID: 18419828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
    Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
    Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel fragments of the Sjögren's syndrome autoantigens alpha-fodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic lymphocyte granule-induced cell death.
    Nagaraju K; Cox A; Casciola-Rosen L; Rosen A
    Arthritis Rheum; 2001 Oct; 44(10):2376-86. PubMed ID: 11665980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas-induced apoptosis is a rare event in Sjögren's syndrome.
    Ohlsson M; Skarstein K; Bolstad AI; Johannessen AC; Jonsson R
    Lab Invest; 2001 Jan; 81(1):95-105. PubMed ID: 11204278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of EBV-mediated alpha-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome.
    Inoue H; Tsubota K; Ono M; Kizu Y; Mizuno F; Takada K; Yamada K; Yanagi K; Hayashi Y; Saito I
    J Immunol; 2001 May; 166(9):5801-9. PubMed ID: 11313424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired Fas signaling pathway is involved in defective T cell apoptosis in autoimmune murine arthritis.
    Zhang J; Bárdos T; Mikecz K; Finnegan A; Glant TT
    J Immunol; 2001 Apr; 166(8):4981-6. PubMed ID: 11290777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.